Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.59 USD | +0.08% | +0.16% | +58.65% |
Jun. 11 | Ono Pharmaceutical Closes Deciphera Deal for About $2.4 Billion | DJ |
Jun. 11 | Deciphera Pharmaceuticals, Inc. Announces Board and Committee Changes | CI |
Financials (USD)
Sales 2024 * | 202M | Sales 2025 * | 250M | Capitalization | 2.21B |
---|---|---|---|---|---|
Net income 2024 * | -164M | Net income 2025 * | -166M | EV / Sales 2024 * | 10.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 8.86 x |
P/E ratio 2024 * |
-13.7
x | P/E ratio 2025 * |
-14.5
x | Employees | 355 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.52% |
Latest transcript on Deciphera Pharmaceuticals, Inc.
1 day | +0.08% | ||
1 week | +0.16% | ||
Current month | +0.20% | ||
1 month | +0.67% | ||
3 months | +60.14% | ||
6 months | +59.64% | ||
Current year | +58.65% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 18-05-16 |
Tucker Kelly
DFI | Director of Finance/CFO | 53 | 15-01-31 |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 18-05-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 2 M€ | -.--% | ||
0.04% | 248 M€ | +14.19% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 25.59 | +0.08% | 1,596,089 |
24-06-07 | 25.57 | +0.08% | 506,790 |
24-06-06 | 25.55 | -0.12% | 1,223,851 |
24-06-05 | 25.58 | +0.04% | 2,012,711 |
Delayed Quote Nasdaq, June 10, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+58.65% | 2.21B | |
+17.73% | 124B | |
+16.88% | 111B | |
-9.04% | 23.17B | |
+5.21% | 22.94B | |
-38.15% | 17.42B | |
-7.75% | 17.42B | |
-14.94% | 16.9B | |
+3.42% | 13.71B | |
+29.63% | 11.82B |
- Stock Market
- Equities
- DCPH Stock